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Abstract
We report the emergence of OXA-232, a newly described
OXA-48-like carbapenemase variant, in Southeast Asia. Molecular
characterization of eight Klebsiella pneumoniae obtained from local
and foreign patients reveals clonality of the isolates. blaOXA-232 was
located on a non-conjugative plasmid of 6141 base pairs (GenBank
accession number JX423831.1).
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The emergence and dissemination of carbapenemase-produc-
ing Enterobacteriaceae is an escalating global threat. As part of
national surveillance efforts performed for carbapenem
non-susceptible clinical Enterobacteriaceae isolates, we
detected the presence of a new OXA-48-like variant,
OXA-232. The novel OXA-232 was only very recently
isolated in France from Enterobacteriaceae of patients who
had travelled to India [1]. To the best of our knowledge, this is
the ﬁrst report providing molecular characterization of eight
isolates carrying blaOXA-232 in Southeast Asia.
The Klebsiella pneumoniae isolates were detected over a
2-month period from March to April 2013, with seven of the
eight isolates originating from one hospital (Table 1). Bacterial
isolates had their species identiﬁcation conﬁrmed using
matrix-assisted laser desorption ionization time-of-ﬂight mass
spectrometry (MALDI-TOF MS; Bruker Daltonics GmHB,
Bremen, Germany). No synergy was displayed with merope-
nem-dipicolinic acid, meropenem-boronic acid or merope-
nem-cloxacillin discs (Rosco Diagnostica A/S, Taastrup,
Denmark), suggesting the absence of metallo-b-lactamases or
class A b-lactamases. Antimicrobial susceptibility testing was
performed with a VITEK-2 instrument and carbapenem MICs
were conﬁrmed with Etest (Biomerieux, Marcy L’Etoile,
France) with susceptibility deﬁned to European Committee
on Antimicrobial Susceptibility Testing breakpoints. The iso-
lates exhibited resistance to carbapenems, with imipenem
MICs in the range of 2–8 mg/L and meropenem MICs ≥32 mg/
L. The isolates were resistant to amikacin and gentamicin
(MICs >256 mg/mL) as well as to levoﬂoxacin (MIC >6 mg/
mL). The isolates were sensitive to tigecycline and colistin
(MICs <1.0 mg/mL).
Screening using PCR for a panel of b-lactamase genes was
performed. This included genes for serine carbapenemases
(KPC-type) [2], metallo-b-lactamases (NDM-type, VIM-type,
IMP-type) [3], OXA-type carbapenemases [4] as well as
extended spectrum b-lactamases (TEM-type, SHV-type,
CTX-M-type, OXA-1, OXA-4, OXA-7, OXA-9) [3].
The PCR screening indicated that isolates were positive for
blaOXA-48. Full gene sequencing of OXA-48-type amplicons
revealed 100% identity with blaOXA-232 (GenBank accession
number JX423831.1). OXA-232 differs from OXA-181 and
OXA-48 by one and ﬁve amino acid substitutions, respectively
[1]. The isolates were negative for KPC, metallo-b-lactamases
and OXA-type extended spectrum b-lactamases. However,
carriage of SHV and CTX-M extended spectrum b-lactamase
genes was observed (Table 1).
Clonal relatedness of the isolates was investigated using
pulsed-ﬁeld gel electrophoresis (PFGE) of K. pneumoniae
genomic DNA digested with the restriction enzyme SpeI.
Visual inspection of the PFGE proﬁles indicated that all eight
isolates belonged to a single pattern type and were therefore
considered to be clonal [5].
Multilocus sequence typing (http://www.pasteur.fr/recher-
che/genopole/PF8/mlst/Kpneumoniae.html) was performed on
a representative isolate, which was determined to belong to
sequence type (ST) 231 (Table 1). Klebsiella pneumoniae of
ST231 have been identiﬁed in international studies as hosts of
carbapenemases, in particular NDM-1 [6,7]. The blaOXA-232
previously reported was found in K. pneumoniae belonging to
ST14 [1]. Conjugation experiments were performed to assess
the transferability of blaOXA-232 from clinical K. pneumoniae
isolates to drug susceptible, azide-resistant recipient
Escherichia coli J53. Transconjugants were selected on Luria–
Bertani agar containing sodium azide (100 mg/L) and
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meropenem (1 mg/L); however, no transconjugants were
obtained, indicating that blaOXA-232 was not transmissible.
The plasmid content of the K. pneumoniae isolates was
analysed. All the isolates had similar plasmidic proﬁles, bearing
plasmids of varying sizes between 4 and 145 kilobases (kb)
(Table 1). Extraction of smaller plasmids using the QIAprep
spin miniprep kits (Qiagen, Hilden, Germany) followed by S1
nuclease digestion revealed the presence of four small plasmids
of 4–9 kb (Table 1). S1 nuclease digestion of whole genomic
DNA followed by PFGE (S1-PFGE) [8] revealed the presence
of two large plasmids of ~70 and 145 kb.
For the identiﬁcation of plasmid incompatibility groups in
the OXA-232 producers, PCR-based replicon typing based on
the protocol by Johnson and Nolan [9] was used. Additionally,
primers (RepCol181-For, 5′-TACGGATTGCGGATGTTGC
C-3′; and RepCol181-Rev, 5′-GTGCTGGTGCGTCCATTTG
G-3′) speciﬁc for the ColE-type replicon of OXA-181-bearing
plasmid (GenBank accession number JN205800.1) were
included [1,10]. Only ColE-type and FIA replicons were
detected (Table 1). Southern hybridization analysis was per-
formed on the S1 nuclease digested miniprep plasmid DNA,
using a 641-base-pair digoxigenin-labelled probe ampliﬁed from
the ColE-type replicon region using primers RepCol181-For
and RepCol181-Rev. The probe hybridized to the 6-kb
plasmid. The data collectively suggested that the 6-kb plasmid
with ColE-type replicon could be similar to the 6.1-kb blaOXA-
232-bearing plasmid [1]. For sequence determination of the
plasmid bearing blaOXA-232, an inverse PCR and primer walking
approach was employed. blaOXA-232 carries a unique SpeI site,
which facilitated the use of inverse PCR. Brieﬂy, plasmid
miniprep extractions of the K. pneumoniae isolates
were subject to SpeI digestion then cleaned-up using a
QIAquick PCR puriﬁcation kit (Qiagen). Then 2 μL of this
preparation were subjected to PCR using primers INV OXA1
(5′-CGATAAGGCTAATACACGCAT-3′) and INV OXA2
(5′-CAGGAGAAAATTATTCCCTAG-3′) that target the
extremities of blaOXA-232, allowing the sequences ﬂanking
blaOXA-232 to be ampliﬁed. An approximately 6-kb DNA
fragment was obtained by PCR and the entire sequence was
determined by primer walking. The sequences for the 6-kb
plasmid were determined for all eight isolates. Sequence analysis
revealed that the 6-kb plasmid in all the isolates was identical to
the 6141-base-pair plasmid characterized by Potron et al. [1].
This plasmid was non-conjugative, which accounted for the lack
of transmissibility of blaOXA-232 in conjugation assays.
Here, we highlight the emergence and outbreak potential of
K. pneumoniae carrying a novel OXA-48-like variant in our
local hospital setting. The isolates were derived from both
local and foreign patients. Molecular proﬁling of the K. pneu-
moniae isolates indicated that they were highly similar, if not
identical. However, because of insufﬁcient clinical information,
we are currently unable to ascertain the exact mechanism of
spread. It remains to be seen if OXA-232 producers will
become established locally, where OXA-181 is currently the
most prevalent OXA-48 type carbapenemase, making up 25%
of all carbapenemase producers in our surveillance studies [4].
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TABLE 1. Characteristics of Klebsiella pneumoniae clinical isolate producing OXA-232
Isolate
Country
of isolation
Country
of origin Hospital Specimen
Date of
isolation ST b-lactamases
Plasmids
Size
(approximate
in kb) Replicon*
KP1 Singapore Indonesia Hospital X Groin 19 March 2013 231 OXA-232, TEM-1, SHV-12, CTX-M-15 4, 5, 6.1, 9, 70, 145 FIA, ColE-like
KP2 Singapore Indonesia Hospital X Abdominal
ﬂuid
22 March 2013 231 OXA-232, TEM-1, SHV-12, CTX-M-15 4, 5, 6.1, 9, 70, 145 FIA, ColE-like
KP3 Singapore Singapore Hospital X Surgical
wound
24 March 2013 231 OXA-232, TEM-1, SHV-12, CTX-M-15 4, 5, 6.1, 9, 70, 145 FIA, ColE-like
KP4 Singapore USA, based
in Indonesia
Hospital X Cerebrospinal
ﬂuid
27 March 2013 231 OXA-232, TEM-1, SHV-12, CTX-M-15 4, 5, 6.1, 9, 70, 145 FIA, ColE-like
KP5 Singapore Bangladesh Hospital X Urine 7 April 2013 231 OXA-232, TEM-1, SHV-12, CTX-M-15 4, 5, 6.1, 9, 70, 145 FIA, ColE-like
KP6 Singapore Singapore Hospital X Sputum 9 April 2013 231 OXA-232, TEM-1, SHV-12, CTX-M-15 4, 5, 6.1, 9, 70, 145 FIA, ColE-like
KP7 Singapore Singapore Hospital X Rectal swab 11 April 2013 231 OXA-232, TEM-1, SHV-12, CTX-M-15 4, 5, 6.1, 9, 70, 145 FIA, ColE-like
KP8 Singapore Singapore Hospital Y Pleural ﬂuid 30 March 2013 231 OXA-232, TEM-1, SHV-12, CTX-M-15 4, 5, 6.1, 9, 70, 145 FIA, ColE-like
ST, Strain type as determined by multilocus sequence typing; ―, information not available.
*Based on PCR-based replicon typing [9] with the inclusion of primers for ColE-type replicon [1].
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